Rush A J, Roffwarg H P, Giles D E, Schlesser M A, Fairchild C, Tarell J
Pharmacopsychiatria. 1983 Nov;16(6):192-4. doi: 10.1055/s-2007-1019497.
Forty-nine patients with major depression and a reduced (less than 65.0 minute) REM latency were treated in a randomized, double-blind study with either amitriptyline or alprazolam. Predictors of response were sought for the whole group and for each drug cell individually. A longer current episode and a higher Beck Depression Inventory to Hamilton Rating Scale ratio were predictive of a poorer response for the whole group and for the alprazolam group. A longer current episode was also predictive of a poor response to amitriptyline. These data suggest that (1) a longer current episode and (2) a greater level of self-reported compared to clinician-observed symptoms correlate with a poorer response to antidepressant medications.
49名患有重度抑郁症且快速眼动睡眠潜伏期缩短(少于65.0分钟)的患者参与了一项随机双盲研究,他们被随机分配接受阿米替林或阿普唑仑治疗。研究分别探寻了整个研究组以及每个药物治疗组的疗效预测因素。对于整个研究组和阿普唑仑治疗组而言,当前发作时间较长以及贝克抑郁量表得分与汉密尔顿抑郁量表得分的比值较高预示着疗效较差。当前发作时间较长对于阿米替林治疗效果差也具有预测作用。这些数据表明:(1)当前发作时间较长;(2)与临床医生观察到的症状相比,自我报告的症状水平较高,这两者均与对抗抑郁药物疗效较差相关。